The role of amiodarone in contemporary management of complex cardiac arrhythmias
- 19 November 2019
- journal article
- review article
- Published by Elsevier BV in Pharmacological Research
- Vol. 151, 104521
- https://doi.org/10.1016/j.phrs.2019.104521
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL131517, R01HL136389)
- German Research Foundation
This publication has 122 references indexed in Scilit:
- Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statementEP Europace, 2013
- Antiarrhythmic Drug Therapy for Atrial FibrillationJournal of the American College of Cardiology, 2012
- Management of amiodarone-related thyroid problemsTherapeutic Advances in Endocrinology and Metabolism, 2011
- Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicityBritish Journal of Clinical Pharmacology, 2009
- Amiodarone‐induced pulmonary toxicityBritish Journal of Clinical Pharmacology, 2008
- Amiodarone induced thrombophlebitisEmergency Medicine Journal, 2006
- Amiodarone versus Sotalol for Atrial FibrillationThe New England Journal of Medicine, 2005
- Basic and Clinical Pharmacology of Amiodarone: Relationship of Antiarrhythmic Effects, Dose and Drug Concentrations to Intracellular Inclusion BodiesThe Journal of Clinical Pharmacology, 1989
- Concentration response relationships of amiodarone and desethylamiodaroneAmerican Heart Journal, 1988
- Amiodarone in Patients on Long-Term DialysisThe New England Journal of Medicine, 1983